This report demonstrates a new method for creating CF3-containing isoxazolone scaffolds, suggesting improved synthesis techniques.
An organobase-controlled regiodivergent approach for the synthesis of CF₃-containing polycyclic spiro-fused and -caged isoxazolone scaffolds is described. This is the first report demonstrating the reactivity of 4-alkylidene isoxazolones in VMA-based cascade reactions in combination with COCF₃-tethered enediones. Additionally, the asymmetric variant of the spiro-fused isoxazolone scaffolds was also achieved using a bifunctional squaramide catalyst. Control experiments confirmed the reversibility and stability of the hemiketal and ketal groups in spiroisoxazolones. Gram-scale synthesis and derivatization further demonstrated the synthetic utility.
No takes yet. Share an insight, caveat, or question.
Khomane et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: